Urology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Tobias-Machado M et al. - Both, RRN and HALRN techniques are accepted minimally invasive options for endoscopic radical nephrectomy with equivalent long term oncological outcome in the treatment of renal tumors.

Related Articles

Thirty-Day Mortality After Nephrectomy: Clinical Implications for Informed Consent
European Urology, 11/10/09    Relevance Score: 90%

Initial experience with robot assisted partial nephrectomy for multiple renal masses
International Braz J Urol, 11/03/09    Relevance Score: 89%

Partial Nephrectomy After Previous Radio Frequency Ablation: The National Cancer Institute Experience
The Journal of Urology, 10/19/09    Relevance Score: 89%

Single-Incision Transureteral Laparoscopic Nephrectomy: A Proof of Concept
Journal of Endourology, 10/27/09    Relevance Score: 88%

Retroperitoneoscopic nephrectomy for crossed-fused ectopic kidney
Indian Journal of Urology, 10/02/09    Relevance Score: 88%

Today in Kidney...keeping you current

Arteriovenous fistula in an autotransplanted kidney segment: Successful angiographic management
Scandinavian Journal of Urology and Nephrology, 12/04/09

NOTES Hybrid Transvaginal Radical Nephrectomy for Tumor: Stepwise Progression Toward a First Successful Clinical Case
European Urology, 12/03/09

Laparoscopic Kidney Transplantation
European Urology, 12/03/09

Today in Laparoscopy...keeping you current

Laparoscopic versus open radical cystectomy for the management of bladder cancer: Mid-term oncological outcome
International Journal of Urology, 12/04/09

Optimizing the Approach for Lymph Node Dissection during Laparoscopic Radical Cystectomy
European Urology, 12/03/09

Laparoscopic orchidopexy: the easy way to go
Journal of Pediatric Surgery, 12/03/09

Today in Oncology...keeping you current

Management of patients with advanced bladder cancer following major response to systemic chemotherapy
Expert Review of Anticancer Therapy, 12/04/09

Degarelix 240/80 mg: a new treatment option for patients with advanced prostate cancer
Expert Review of Anticancer Therapy, 12/04/09

The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer
Cancer Treatment Reviews, 12/04/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address